{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:32:35Z","timestamp":1761921155945},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Immune checkpoint inhibitors (ICIs) are promising agents for treating melanoma. Given that autoimmune skin diseases exhibit hyper immune reaction, investigation of immune cells from autoimmune skin disease is crucial to validate the effectiveness of ICIs in melanoma treatment. We employed multipanel markers to predict the response to immune checkpoint inhibitors by characterizing the gene expression signatures of skin immune cells in systemic lupus erythematosus (SLE), atopic dermatitis (AD), and psoriasis (PS). By analyzing single-cell RNA sequencing data from each dataset, T cell gene signatures from autoimmune skin diseases exhibit a complex immune response in tumors that responded to immunotherapy. Based on that CD86 and CD80 provide essential costimulatory signals for T cell activation, we observed that interaction of CD86 signaling has been enhanced in the T cells of patients with SLE, AD, and PS. Our analysis revealed a common increase in CD86 signals from dendritic cells (DCs) to T cells in patients with SLE, AD, and PS, confirming that dendritic cells produce pro-inflammatory cytokines to activate T cells. Thus, we hypothesize that T cell gene signatures from autoimmune skin diseases exhibit a pro-inflammatory response and have the potential to predict cancer immunotherapy. Our study demonstrated that T cell gene signatures derived from inflammatory skin diseases, particularly SLE and PS, hold promise as potential biomarkers for predicting the response to immune checkpoint blockade therapy in patients with melanoma. Our data provide an understanding of the immune-related characteristics and differential gene expression patterns in autoimmune skin diseases, which may represent promising targets for melanoma immunotherapy.<\/jats:p>","DOI":"10.1038\/s41598-023-42238-3","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T10:02:57Z","timestamp":1694512977000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanoma"],"prefix":"10.1038","volume":"13","author":[{"given":"Kyu-Hye","family":"Chun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye-Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo Kyung","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungsoon","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"key":"42238_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.950973","author":"J Wang","year":"2022","unstructured":"Wang, J., Cui, B., Chen, Z. & Ding, X. The regulation of skin homeostasis, repair and the pathogenesis of skin diseases by spatiotemporal activation of epidermal mTOR signaling. Front. Cell Dev. Biol. https:\/\/doi.org\/10.3389\/fcell.2022.950973 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"42238_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nrm2636","volume":"10","author":"C Blanpain","year":"2009","unstructured":"Blanpain, C. & Fuchs, E. Epidermal homeostasis: A balancing act of stem cells in the skin. Nat. Rev. Mol. Cell Biol. 10, 207\u2013217. https:\/\/doi.org\/10.1038\/nrm2636 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"42238_CR3","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3349\/ymj.2010.51.6.924","volume":"51","author":"DH Yang","year":"2010","unstructured":"Yang, D. H., Chang, D. M., Lai, J. H., Lin, F. H. & Chen, C. H. Significantly higher percentage of circulating CD27(high) plasma cells in systemic lupus erythematosus patients with infection than with disease flare-up. Yonsei Med. J. 51, 924\u2013931. https:\/\/doi.org\/10.3349\/ymj.2010.51.6.924 (2010).","journal-title":"Yonsei Med. J."},{"key":"42238_CR4","doi-asserted-by":"publisher","first-page":"18020","DOI":"10.1038\/s41598-020-74798-z","volume":"10","author":"N Acevedo","year":"2020","unstructured":"Acevedo, N. et al. Epigenetic alterations in skin homing CD4+CLA+ T cells of atopic dermatitis patients. Sci. Rep. 10, 18020. https:\/\/doi.org\/10.1038\/s41598-020-74798-z (2020).","journal-title":"Sci. Rep."},{"key":"42238_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3349\/ymj.2006.47.3.293","volume":"47","author":"SH Lee","year":"2006","unstructured":"Lee, S. H., Jeong, S. K. & Ahn, S. K. An update of the defensive barrier function of skin. Yonsei Med. J. 47, 293\u2013306 (2006).","journal-title":"Yonsei Med. J."},{"key":"42238_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","volume":"16","author":"L Pan","year":"2020","unstructured":"Pan, L., Lu, M. P., Wang, J. H., Xu, M. & Yang, S. R. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J. Pediatr. 16, 19\u201330. https:\/\/doi.org\/10.1007\/s12519-019-00229-3 (2020).","journal-title":"World J. Pediatr."},{"key":"42238_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","volume":"387","author":"S Weidinger","year":"2016","unstructured":"Weidinger, S. & Novak, N. Atopic dermatitis. The Lancet 387, 1109\u20131122. https:\/\/doi.org\/10.1016\/S0140-6736(15)00149-X (2016).","journal-title":"The Lancet"},{"key":"42238_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1165098","author":"M Napolitano","year":"2023","unstructured":"Napolitano, M., di Vico, F., Ruggiero, A., Fabbrocini, G. & Patruno, C. The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis. Front. Med. https:\/\/doi.org\/10.3389\/fmed.2023.1165098 (2023).","journal-title":"Front. Med."},{"key":"42238_CR9","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.jaci.2020.02.021","volume":"145","author":"DYM Leung","year":"2020","unstructured":"Leung, D. Y. M., Berdyshev, E. & Goleva, E. Cutaneous barrier dysfunction in allergic diseases. J. Allergy Clin. Immunol. 145, 1485\u20131497. https:\/\/doi.org\/10.1016\/j.jaci.2020.02.021 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"42238_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5114\/ada.2020.96243","volume":"37","author":"B Nedoszytko","year":"2020","unstructured":"Nedoszytko, B. et al. Pathogenesis of psoriasis in the \u201comic\u201d era. Part II. Genetic, genomic and epigenetic changes in psoriasis. Postepy Dermatol. Alergol. 37, 283\u2013298. https:\/\/doi.org\/10.5114\/ada.2020.96243 (2020).","journal-title":"Postepy Dermatol. Alergol."},{"key":"42238_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475","author":"A Rendon","year":"2019","unstructured":"Rendon, A. & Sch\u00e4kel, K. Psoriasis pathogenesis and treatment. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20061475 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"42238_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.788940","author":"P Hu","year":"2021","unstructured":"Hu, P. et al. The role of helper T cells in psoriasis. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.788940 (2021).","journal-title":"Front. Immunol."},{"key":"42238_CR13","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3349\/ymj.2022.0160","volume":"63","author":"S Moon","year":"2022","unstructured":"Moon, S., Jang, Y. K., Shin, J. U., Kim, D. H. & Lee, H. J. Innate Immunity protein markers are significantly elevated in hidradenitis suppurativa skin than in psoriasis vulgaris. Yonsei Med. J. 63, 971\u2013973. https:\/\/doi.org\/10.3349\/ymj.2022.0160 (2022).","journal-title":"Yonsei Med. J."},{"key":"42238_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes, M. A., Su\u00e1rez-Fari\u00f1as, M. & Krueger, J. G. Immunology of psoriasis. Annu. Rev. Immunol. 32, 227\u2013255. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120225 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"42238_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0092-8674(95)90047-0","volume":"82","author":"NK Nanda","year":"1995","unstructured":"Nanda, N. K. & Sercarz, E. E. Induction of anti-self-immunity to cure cancer. Cell 82, 13\u201317. https:\/\/doi.org\/10.1016\/0092-8674(95)90047-0 (1995).","journal-title":"Cell"},{"key":"42238_CR16","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.3390\/ijms22115729","volume":"22","author":"GS Bocheva","year":"2021","unstructured":"Bocheva, G. S., Slominski, R. M. & Slominski, A. T. Immunological aspects of skin aging in atopic dermatitis. Int. J. Mol. Sci. 22, 5729 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"42238_CR17","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/curroncol29050247","volume":"29","author":"Y Shiravand","year":"2022","unstructured":"Shiravand, Y. et al. Immune checkpoint inhibitors in cancer therapy. Curr. Oncol. 29, 3044\u20133060. https:\/\/doi.org\/10.3390\/curroncol29050247 (2022).","journal-title":"Curr. Oncol."},{"key":"42238_CR18","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443\u20132454. https:\/\/doi.org\/10.1056\/NEJMoa1200690 (2012).","journal-title":"N. Engl. J. Med."},{"key":"42238_CR19","doi-asserted-by":"publisher","first-page":"eabn2263","DOI":"10.1126\/scitranslmed.abn2263","volume":"14","author":"AC Billi","year":"2022","unstructured":"Billi, A. C. et al. Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation. Sci. Transl. Med. 14, eabn2263. https:\/\/doi.org\/10.1126\/scitranslmed.abn2263 (2022).","journal-title":"Sci. Transl. Med."},{"key":"42238_CR20","doi-asserted-by":"publisher","first-page":"630892","DOI":"10.3389\/fimmu.2021.630892","volume":"12","author":"K Rindler","year":"2021","unstructured":"Rindler, K. et al. Spontaneously resolved atopic dermatitis shows melanocyte and immune cell activation distinct from healthy control skin. Front. Immunol. 12, 630892. https:\/\/doi.org\/10.3389\/fimmu.2021.630892 (2021).","journal-title":"Front. Immunol."},{"key":"42238_CR21","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jaci.2021.04.021","volume":"148","author":"J Kim","year":"2021","unstructured":"Kim, J. et al. Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets. J. Allergy Clin. Immunol. 148, 1281\u20131292. https:\/\/doi.org\/10.1016\/j.jaci.2021.04.021 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"42238_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296. https:\/\/doi.org\/10.1186\/s13059-019-1874-1 (2019).","journal-title":"Genome Biol."},{"key":"42238_CR23","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573-3587.e3529. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048 (2021).","journal-title":"Cell"},{"key":"42238_CR24","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296. https:\/\/doi.org\/10.1038\/s41592-019-0619-0 (2019).","journal-title":"Nat. Methods"},{"key":"42238_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: Tool for the unification of biology. Nat. Genet. 25, 25\u201329. https:\/\/doi.org\/10.1038\/75556 (2000).","journal-title":"Nat. Genet."},{"key":"42238_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-Seq data. BMC Bioinf. 14, 7. https:\/\/doi.org\/10.1186\/1471-2105-14-7 (2013).","journal-title":"BMC Bioinf."},{"key":"42238_CR27","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/all.15104","volume":"77","author":"I Kortekaas Krohn","year":"2022","unstructured":"Kortekaas Krohn, I. et al. T-cell subsets in the skin and their role in inflammatory skin disorders. Allergy 77, 827\u2013842. https:\/\/doi.org\/10.1111\/all.15104 (2022).","journal-title":"Allergy"},{"key":"42238_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1081999","author":"C Zheng","year":"2023","unstructured":"Zheng, C., Shi, Y. & Zou, Y. T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1081999 (2023).","journal-title":"Front. Immunol."},{"key":"42238_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jdermsci.2018.01.005","volume":"90","author":"CTH Nguyen","year":"2018","unstructured":"Nguyen, C. T. H. et al. Up-regulated expression of CD86 on circulating intermediate monocytes correlated with disease severity in psoriasis. J. Dermatol. Sci. 90, 135\u2013143. https:\/\/doi.org\/10.1016\/j.jdermsci.2018.01.005 (2018).","journal-title":"J. Dermatol. Sci."},{"key":"42238_CR30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1600-065X.2011.01011.x","volume":"241","author":"H Bour-Jordan","year":"2011","unstructured":"Bour-Jordan, H. et al. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28\/ B7 family. Immunol. Rev. 241, 180\u2013205. https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01011.x (2011).","journal-title":"Immunol. Rev."},{"key":"42238_CR31","doi-asserted-by":"publisher","first-page":"26762","DOI":"10.1074\/jbc.271.43.26762","volume":"271","author":"JL Greene","year":"1996","unstructured":"Greene, J. L. et al. Covalent dimerization of CD28\/CTLA-4 and oligomerization of CD80\/CD86 regulate T cell costimulatory interactions. J. Biol. Chem. 271, 26762\u201326771. https:\/\/doi.org\/10.1074\/jbc.271.43.26762 (1996).","journal-title":"J. Biol. Chem."},{"key":"42238_CR32","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1002\/eji.200838342","volume":"38","author":"Y Berkun","year":"2008","unstructured":"Berkun, Y. et al. Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus. Eur. J. Immunol. 38, 2896\u20132904. https:\/\/doi.org\/10.1002\/eji.200838342 (2008).","journal-title":"Eur. J. Immunol."},{"key":"42238_CR33","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s004030100263","volume":"293","author":"E Schuller","year":"2001","unstructured":"Schuller, E. et al. In situ expression of the costimulatory molecules CD80 and CD86 on langerhans cells and inflammatory dendritic epidermal cells (IDEC) in atopic dermatitis. Arch. Dermatol. Res. 293, 448\u2013454. https:\/\/doi.org\/10.1007\/s004030100263 (2001).","journal-title":"Arch. Dermatol. Res."},{"key":"42238_CR34","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1046\/j.1365-2133.1997.01836.x","volume":"136","author":"O Ohki","year":"1997","unstructured":"Ohki, O. et al. Functional CD86 (B7\u20132\/B70) is predominantly expressed on Langerhans cells in atopic dermatitis. Br. J. Dermatol. 136, 838\u2013845. https:\/\/doi.org\/10.1046\/j.1365-2133.1997.01836.x (1997).","journal-title":"Br. J. Dermatol."},{"key":"42238_CR35","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.4049\/jimmunol.154.6.2668","volume":"154","author":"RS Mitra","year":"1995","unstructured":"Mitra, R. S., Judge, T. A., Nestle, F. O., Turka, L. A. & Nickoloff, B. J. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7\u20131 (CD80) and B7\u20132 (CD86) expression. J. Immunol. 154, 2668\u20132677 (1995).","journal-title":"J. Immunol."},{"key":"42238_CR36","doi-asserted-by":"publisher","first-page":"102291","DOI":"10.1016\/j.jaut.2019.06.002","volume":"103","author":"SJ Wolf","year":"2019","unstructured":"Wolf, S. J. et al. Ultraviolet light induces increased T cell activation in lupus-prone mice via type I IFN-dependent inhibition of T regulatory cells. J. Autoimmun. 103, 102291. https:\/\/doi.org\/10.1016\/j.jaut.2019.06.002 (2019).","journal-title":"J. Autoimmun."},{"key":"42238_CR37","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/art.23268","volume":"58","author":"B Yan","year":"2008","unstructured":"Yan, B. et al. Dysfunctional CD4+, CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum 58, 801\u2013812. https:\/\/doi.org\/10.1002\/art.23268 (2008).","journal-title":"Arthritis Rheum"},{"key":"42238_CR38","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1126\/science.1064890","volume":"294","author":"P Blanco","year":"2001","unstructured":"Blanco, P., Palucka, A. K., Gill, M., Pascual, V. & Banchereau, J. Induction of dendritic cell differentiation by IFN-\u03b1 systemic lupus erythematosus. Science 294, 1540\u20131543. https:\/\/doi.org\/10.1126\/science.1064890 (2001).","journal-title":"Science"},{"key":"42238_CR39","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/eci.12130","volume":"43","author":"EA Frangou","year":"2013","unstructured":"Frangou, E. A., Bertsias, G. K. & Boumpas, D. T. Gene expression and regulation in systemic lupus erythematosus. Eur. J. Clin. Invest. 43, 1084\u20131096. https:\/\/doi.org\/10.1111\/eci.12130 (2013).","journal-title":"Eur. J. Clin. Invest."},{"key":"42238_CR40","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/biomedicines11030864","volume":"11","author":"V Demers-Mathieu","year":"2023","unstructured":"Demers-Mathieu, V. Optimal selection of IFN-&alpha;-inducible genes to determine type I interferon signature improves the diagnosis of systemic lupus erythematosus. Biomedicines 11, 864 (2023).","journal-title":"Biomedicines"},{"key":"42238_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jaci.2007.11.003","volume":"121","author":"AJ Reefer","year":"2008","unstructured":"Reefer, A. J. et al. Analysis of CD25hiCD4+ \u201cregulatory\u201d T-cell subtypes in atopic dermatitis reveals a novel TH2-like population. J. Allergy Clin. Immunol. 121, 415-422.e413. https:\/\/doi.org\/10.1016\/j.jaci.2007.11.003 (2008).","journal-title":"J. Allergy Clin. Immunol."},{"key":"42238_CR42","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/exd.12563","volume":"23","author":"S Jin","year":"2014","unstructured":"Jin, S. et al. DAMP molecules S100A9 and S100A8 activated by IL-17A and house-dust mites are increased in atopic dermatitis. Exp. Dermatol. 23, 938\u2013941. https:\/\/doi.org\/10.1111\/exd.12563 (2014).","journal-title":"Exp. Dermatol."},{"key":"42238_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1755-8794-3-15","volume":"3","author":"B Mesko","year":"2010","unstructured":"Mesko, B. et al. Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets. BMC Med. Genomics 3, 15. https:\/\/doi.org\/10.1186\/1755-8794-3-15 (2010).","journal-title":"BMC Med. Genomics"},{"key":"42238_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3349\/ymj.2022.63.1.42","volume":"63","author":"C-B Synn","year":"2022","unstructured":"Synn, C.-B. et al. primary tumor suppression and systemic immune activation of macrophages through the sting pathway in metastatic skin tumor. Yonsei Med. J. 63, 42\u201355 (2022).","journal-title":"Yonsei Med. J."},{"key":"42238_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.842496","author":"RM Slominski","year":"2022","unstructured":"Slominski, R. M. et al. Melanoma, melanin, and melanogenesis: The Yin and Yang relationship. Front. Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.842496 (2022).","journal-title":"Front. Oncol."},{"key":"42238_CR46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.tins.2023.01.003","volume":"46","author":"RM Slominski","year":"2023","unstructured":"Slominski, R. M., Raman, C., Chen, J. Y. & Slominski, A. T. How cancer hijacks the body\u2019s homeostasis through the neuroendocrine system. Trends Neurosci. 46, 263\u2013275. https:\/\/doi.org\/10.1016\/j.tins.2023.01.003 (2023).","journal-title":"Trends Neurosci."},{"key":"42238_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12929-017-0341-0","volume":"24","author":"H-F Tsai","year":"2017","unstructured":"Tsai, H.-F. & Hsu, P.-N. Cancer immunotherapy by targeting immune checkpoints: Mechanism of T cell dysfunction in cancer immunity and new therapeutic targets. J. Biomed. Sci. 24, 35. https:\/\/doi.org\/10.1186\/s12929-017-0341-0 (2017).","journal-title":"J. Biomed. Sci."},{"key":"42238_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02306","author":"C Paluch","year":"2018","unstructured":"Paluch, C., Santos, A. M., Anzilotti, C., Cornall, R. J. & Davis, S. J. Immune checkpoints as therapeutic targets in autoimmunity. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.02306 (2018).","journal-title":"Front. Immunol."},{"key":"42238_CR49","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow, A., Perica, K., Klebanoff, C. A. & Wolchok, J. D. Clinical implications of T cell exhaustion for cancer immunotherapy. Nat. Rev. Clin. Oncol. 19, 775\u2013790. https:\/\/doi.org\/10.1038\/s41571-022-00689-z (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"42238_CR50","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1056\/NEJMoa1613493","volume":"376","author":"DP Carbone","year":"2017","unstructured":"Carbone, D. P. et al. First-line nivolumab in stage IV or recurrent non-small-cell lung cancer. N. Engl. J. Med. 376, 2415\u20132426. https:\/\/doi.org\/10.1056\/NEJMoa1613493 (2017).","journal-title":"N. Engl. J. Med."},{"key":"42238_CR51","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi, N. A. et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348, 124\u2013128. https:\/\/doi.org\/10.1126\/science.aaa1348 (2015).","journal-title":"Science"},{"key":"42238_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","volume":"20","author":"SK Wculek","year":"2020","unstructured":"Wculek, S. K. et al. Dendritic cells in cancer immunology and immunotherapy. Nat. Rev. Immunol. 20, 7\u201324. https:\/\/doi.org\/10.1038\/s41577-019-0210-z (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"42238_CR53","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.4049\/jimmunol.170.3.1257","volume":"170","author":"JA Brown","year":"2003","unstructured":"Brown, J. A. et al. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 170, 1257\u20131266. https:\/\/doi.org\/10.4049\/jimmunol.170.3.1257 (2003).","journal-title":"J. Immunol."},{"key":"42238_CR54","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nri1131","volume":"3","author":"CE Rudd","year":"2003","unstructured":"Rudd, C. E. & Schneider, H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat. Rev. Immunol. 3, 544\u2013556. https:\/\/doi.org\/10.1038\/nri1131 (2003).","journal-title":"Nat. Rev. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42238-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42238-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42238-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T05:05:29Z","timestamp":1700456729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42238-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["42238"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-42238-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]},"assertion":[{"value":"21 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15023"}}